The effectiveness of new treatment modalities, such as targeted therapy and immunotherapy, has been a major focus of recent cancer studies. Targeted therapies, which aim to attack cancer cells specifically without harming normal cells, have shown remarkable success in treating cancers that were previously difficult to manage. Immunotherapy, which harnesses the body's immune system to fight cancer, has led to significant improvements in survival rates for cancers such as melanoma and lung cancer.
